Structure of the HLTF HIRAN domain and its functional implications in regression of a stalled replication fork.

DNA-damage tolerance HIRAN crystal structure protein–DNA interaction replication-fork regression template-switched DNA synthesis

Journal

Acta crystallographica. Section D, Structural biology
ISSN: 2059-7983
Titre abrégé: Acta Crystallogr D Struct Biol
Pays: United States
ID NLM: 101676043

Informations de publication

Date de publication:
01 Aug 2020
Historique:
received: 10 03 2020
accepted: 16 06 2020
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 10 7 2021
Statut: ppublish

Résumé

HLTF (helicase-like transcription factor) is a yeast RAD5 homolog that is found in mammals. HLTF has E3 ubiquitin ligase and DNA helicase activities, and is a pivotal protein in template-switched DNA synthesis that allows DNA replication to continue even in the presence of DNA damage by utilizing a newly synthesized undamaged strand as a template. In addition, HLTF has a DNA-binding domain termed HIRAN (HIP116 and RAD5 N-terminal). HIRAN has been hypothesized to play a role in DNA binding; however, the structural basis of its role in DNA binding has remained unclear. In the past five years, several crystal structures of HIRAN have been reported. These structures revealed new insights into the molecular mechanism underlying DNA binding by HIRAN. Here, the structural information on HIRAN is summarized and the function of HIRAN in recognizing the 3'-terminus of the daughter strand at a stalled replication fork and the implications for its involvement in fork regression are discussed.

Identifiants

pubmed: 32744255
pii: S2059798320008074
doi: 10.1107/S2059798320008074
doi:

Substances chimiques

DNA-Binding Proteins 0
HLTF protein, human 0
Transcription Factors 0
DNA 9007-49-2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-735

Subventions

Organisme : Osaka University
ID : VFCR-14-02
Organisme : Japan Society for the Promotion of Science
ID : 25291017
Organisme : Japan Society for the Promotion of Science
ID : 16H04755
Organisme : Japan Society for the Promotion of Science
ID : 17H06014

Auteurs

Asami Hishiki (A)

School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8002, Japan.

Mamoru Sato (M)

Graduate School of Medical Life Sciences, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.

Hiroshi Hashimoto (H)

School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8002, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH